Table 3.
k | SMD | 95% CI | p | Q | I 2 | |
---|---|---|---|---|---|---|
Duration | ||||||
30-90 days | 12 | -1.6 | -2.47; -0.74 | <0.001 | 64.36 | 0.83 |
>90 days | 7 | -1.20 | -2.13; -0.28 | <0.001 | 14.66 | 0.59 |
Training state | ||||||
Higher | 10 | -1.91 | -2.57; -1.25 | <0.001 | 28.8 | 0.69 |
Lower | 4 | -0.85 | -1.83; 0.12 | <0.001 | 24.5 | 0.67 |
Age | ||||||
<20b | 3 | -2.81 | -6.32; 0.69 | <0.001 | 5.04 | 0.63 |
≥20 | 16 | -1.20 | -1.76; -0.64 | <0.001 | 58.4 | 0.74 |
Format | ||||||
CDT | 16 | -1.69 | -2.41; -0.96 | <0.001 | 52.5 | 0.73 |
PDT | 4 | -0.65 | -1.42; 0.11 | <0.001 | 9.2 | 0.67 |
k: number of studies; SMD: <-0.5, small; 0.5 to 0.8, moderate; and >0.8, large; I2: heterogeneity test.